KLOW is supplied as a lyophilized vial combining four extensively studied research peptides — GHK-Cu, BPC-157, TB-500, and KPV — in one formulation for laboratory research. Available in 80mg total strength with lot-coded traceability and tamper-evident packaging.
KLOW is supplied as a lyophilized vial combining four extensively studied research peptides — GHK-Cu, BPC-157, TB-500, and KPV — in one formulation for laboratory research. Available in 80mg total strength with lot-coded traceability and tamper-evident packaging.
$129.99
KLOW is a four-compound research blend combining GHK-Cu (a copper-binding tripeptide), BPC-157 (a synthetic peptide studied for tissue-repair pathway research), TB-500 (a synthetic fragment of thymosin beta-4), and KPV (the C-terminal tripeptide of alpha-MSH). Each compound is independently studied across tissue-remodeling, angiogenesis, and inflammatory-pathway research literature, and this formulation is supplied for laboratories investigating them in combination. Supplied as a lyophilized powder in a sealed 80mg vial, with lot-coded traceability and tamper-evident packaging carried through fulfillment.
In laboratory literature, this blend combines four independently studied research peptides — GHK-Cu, BPC-157, TB-500, and KPV — each associated with distinct tissue-repair, angiogenesis, and anti-inflammatory pathway research.
A lyophilized (freeze-dried) powder in a sealed glass vial, ready for reconstitution per your lab’s protocol.
Yes — third-party content verification for each of the four compounds in the current lot is published above.
Every vial carries an internal lot code tied to our traceability log, plus tamper-evident sealing maintained from fulfillment through delivery.
No. This product is sold strictly for laboratory research use by qualified researchers, and is not a drug, dietary supplement, or medical device.
Orders are prepared from lot-tracked inventory and shipped in tamper-evident packaging with tracking information.
